Recombinant Human S1pr2 Protein，His

S1PR2 (Sphingosine-1-phosphate receptor 2) is a member of the sphingosine-1-phosphate receptor family, which plays a crucial role in various physiological processes, including immune response, lymphocyte trafficking, and vascular stability. Research into S1PR2 has gained attention due to its involvement in several pathophysiological conditions, such as autoimmune diseases, cardiovascular disorders, and cancer. Understanding the structure and function of the S1PR2 protein can provide insights into its signaling pathways and interactions with ligands and downstream effectors. The characterization of S1PR2 through recombinant protein techniques allows for the detailed study of its functional mechanisms, including its impact on cellular migration, proliferation, and survival. Moreover, S1PR2's potential as a therapeutic target in conditions like multiple sclerosis and cancer makes it a significant focus of drug development efforts. Advances in recombinant DNA technology facilitate the production of S1PR2 in heterologous systems, enabling researchers to investigate its pharmacological properties and discover novel modulators that can selectively influence its activity. This research not only enhances the understanding of sphingosine phosphate signaling but also paves the way for innovative treatments aimed at modulating S1PR2 activity to address a range of diseases. As such, the study of S1PR2 recombinant proteins is poised to contribute significantly to the fields of molecular biology and pharmacotherapy.